Showing 1601-1610 of 20878 results for "".
- Emerging Targets in Oncology: Advances in Pan-RAS Inhibitors and Translational Strategieshttps://reachmd.com/news/targets-oncology-pan-ras-inhibitors-translational-strategies/2484607/RMC-6236 has shown early pan‑RAS activity, with a recent review reporting preliminary disease‑control rates of approximately 85–87% across initial cohorts and signals of objective responses in
- Reevaluating Mean Arterial Pressure Targets in Vasodilatory Shock: Implications for Emergency Carehttps://reachmd.com/news/mean-arterial-pressure-targets-vasodilatory-shock/2484597/A recent systematic review and meta-analysis identified a mortality signal when comparing higher versus lower mean arterial pressure (MAP) targets in vasodilatory shock. Pool
- Transforming Antenatal Care: The Impact of Decentralized Ultrasound Services in South Africahttps://reachmd.com/news/transforming-antenatal-care-the-impact-of-decentralized-ultrasound-services-in-south-africa/2484565/Decentralizing routine antenatal ultrasound into a rural South African primary health center meaningfully increased access and shifted gestational dating earlier—scans before 24 weeks rose from 52% to 66%, broadening the window for accurate dating and early anomaly screening.
- Advancements in Minimally Invasive Prostate Cancer Therapies: The Emerging Role of Focal One HIFUhttps://reachmd.com/news/advancements-in-minimally-invasive-prostate-cancer-therapies-the-emerging-role-of-focal-one-hifu/2484547/The Focal One HIFU system received FDA 510(k) clearance, advancing image‑guided prostate ablation with improved ultrasound imaging and a streamlined workflow. The clearance covers technical upgrades without expanding the therapeutic indication, and the net clinical implicat
- Emerging Infectious Threats: Neonatal Sepsis and the ByHeart Formula Recallhttps://reachmd.com/news/emerging-infectious-threats-neonatal-sepsis-and-the-byheart-formula-recall/2484564/ByHeart formula has been linked to 31 affected infants across 15 states as of Nov. 20, 2025; all
- Reprogramming the Liver in Obesity: Methylation, Transcription Factors, and Proteomic Insightshttps://reachmd.com/news/reprogramming-liver-obesity-methylome-transcriptome-proteome/2484538/A transomic study integrating the methylome, transcriptome, and proteome demonstrates how obesity remodels the hepatic proteome through coordinated epigenetic and transcriptional chang
- Emerging Influenza Threat: New Variant Challenges U.S. Seasonal Preparednesshttps://reachmd.com/news/emerging-influenza-threat-new-variant-challenges-us-seasonal-preparedness/2484553/The influenza subclade K variant is spreading internationally and could presage a more severe U.S. influenza season. Rising counts in multiple high-surveillance countries, coup
- Trial for First Oral Minoxidil for Female Hair Loss Initiates Phase 3https://reachmd.com/news/trial-for-first-oral-minoxidil-for-female-hair-loss-launches-phase-3/2484534/Veradermics, Inc. announced the initiation of patient enrollment in a phase 2/3 registration-directed clinical trial of VDPHL01, a novel extended-release oral minoxidil formulation, according to a press release. If approved, V
- The Impact of Nurse Staffing on Physician Burnout: Insights and Interventionshttps://reachmd.com/news/the-impact-of-nurse-staffing-on-physician-burnout-insights-and-interventions/2484541/Better nurse staffing is associated with substantial reductions in physician burnout among hospital physicians, signaling improved clinician well-being and more stabl
- Innovative Imaging Shifts Paradigms in Renal Mass Managementhttps://reachmd.com/news/innovative-imaging-shifts-paradigms-in-renal-mass-management/2484552/A ZIRCON‑X press release reports that TLX250‑CDx PET/CT changed clinical management in 48.6% of patients with indeterminate renal masses. The